With investment in the gene therapy space at an all-time high and more approvals on the horizon, the commercial reality of gene therapies is beginning to be realised.
However, these therapies cannot be pioneered without contract service providers who have the expertise, flexibility, and capability to meet drug developer demands.
Senior decision-makers from top gene therapy companies will virtually unite at the 4th Annual
Gene Therapy for Rare Disorders Europe, seeking collaborations with organisations that they believe will accelerate their gene therapy development.
If you have capabilities that would benefit our audience in the gene therapy space, this online meeting will provide a unique platform to showcase your solutions, generate new business leads and source opportunities for partnerships.
"First time we participated to this meeting. All the main players in Cell and Gene Therapy were gathered. Perfectly organized, good size to meet and network."
Director, Business Development
Get in touch today to learn more about how we can build a bespoke partnership
to support your business development objectives.